Immunosuppression is the typical measure to prevent rejection after heart transplantation.
Although rejection is the usual cause of cardiac hypertrophy, numerous other factors warrant …

Background. Hypertrophic cardiomyopathy (HCM) in pediatric solid organ transplant
recipients has been reported in association with use of calcineurin inhibitors. However, data …

We present 3 heart transplant recipients who developed hypertrophic cardiomyopathy years
after transplantation. In all 3 cases, the diagnosis was initially made based on …

Remarkably, our patient has done well in the 19 years since her transplant, highlighting the
importance of vigilant screening to detect non–transplant-related pathologies and the …

A35-year-old man was admitted with pitting edema on both lower legs, dyspnea on exertion,
and orthopnea for 2 months before presentation. He had undergone cardiac transplantation …

Cardiac Allograft Hypertrophy: A New Target for Therapy, a Surrogate Marker for Survival? -
Torre‐Amione - 2009 - American Journal of Transplantation - Wiley Online Library Skip to …

Left ventricular hypertrophy associated with the use of tacrolimus is a rare complication of
solid organ transplantation in adult recipients. We present a cardiac transplant recipient who …

A woman with advanced coronary artery disease underwent heart transplantation. The
donor heart had left ventricular hypertrophy. The electrocardiographic and …

After orthotopic heart transplantation (OHT), the allograft undergoes characteristic alterations
in myocardial structure, including hypertrophy, increased ventricular stiffness, ischemia, and …

Background Left ventricular apical hypertrophic cardiomyopathy is a rare presentation of
hypertrophic cardiomyopathy associated with thickening of the apical segment of the left …